BA541Case7 - BA541 Business Ethics Lesson #4 Assignment #5...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
BA541 Business Ethics Lesson #4 Assignment #5 Read Case #7, "Samuel Waksal and ImClone," on pages 148-150 of Business Ethics: A Stakeholder and Issues Management Approach (4th Edition). Consider and respond to the following questions. 1. What might motivate an individual or a company to shortcut drug testing that is crucial for FDA approval? The faster a drug can get approved, the faster patients may be helped by it. In the case of a cancer treatment especially, time is of the essence. In terms of financial reasons, the sooner a drug gets FDA approval, apparently the more likely it is to be used by the medical community over another drug in the same class. It is not until second generation medications come around that health care providers may consider changing their prescribing habits. Another reason why a single-armed study may be used is due to a shortage of subjects or if the treatment is so effective that it becomes unethical to allow the other subjects to be in the control group and not receive the treatment. In the case of ImClone, although the Sam Waksal situation suggests the rush was to
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 2

BA541Case7 - BA541 Business Ethics Lesson #4 Assignment #5...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online